The global Predictive and Presymptomatic Testing market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
Predictive genetic testing searches for genetic changes, or mutations, that are linked to disease. These tests are done before you show any signs of a disease.听
This report is a detailed and comprehensive analysis for global Predictive and Presymptomatic Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Predictive and Presymptomatic Testing market size and forecasts, in consumption value ($ Million), 2020-2031
Global Predictive and Presymptomatic Testing market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Predictive and Presymptomatic Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Predictive and Presymptomatic Testing market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Predictive and Presymptomatic Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Predictive and Presymptomatic Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include 23andMe, Inc., Abbott Molecular, Inc., BioAxis DNA Research Centre Private Limited, Color Genomics, Inc., Direct Laboratory Services LLC (DirectLabs), Gene by Gene Ltd., Genomic Diagnostics, Mapmygenome, Myriad Genetics, Inc., Pathway Genomics Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Predictive and Presymptomatic Testing market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Presymptomatic Testing
Predispositional Testing
Market segment by Application
Breast and Ovarian Cancer
Colorectal Cancer
Alzheimer's Disease
Multiple Endocrine Neoplasia Type 2
Haemochromatosis
Market segment by players, this report covers
23andMe, Inc.
Abbott Molecular, Inc.
BioAxis DNA Research Centre Private Limited
Color Genomics, Inc.
Direct Laboratory Services LLC (DirectLabs)
Gene by Gene Ltd.
Genomic Diagnostics
Mapmygenome
Myriad Genetics, Inc.
Pathway Genomics Corporation
Positive Bioscience, Inc.
Quest Diagnostics, Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Predictive and Presymptomatic Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Predictive and Presymptomatic Testing, with revenue, gross margin, and global market share of Predictive and Presymptomatic Testing from 2020 to 2025.
Chapter 3, the Predictive and Presymptomatic Testing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Predictive and Presymptomatic Testing market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Predictive and Presymptomatic Testing.
Chapter 13, to describe Predictive and Presymptomatic Testing research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Predictive and Presymptomatic Testing by Type
1.3.1 Overview: Global Predictive and Presymptomatic Testing Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Predictive and Presymptomatic Testing Consumption Value Market Share by Type in 2024
1.3.3 Presymptomatic Testing
1.3.4 Predispositional Testing
1.4 Global Predictive and Presymptomatic Testing Market by Application
1.4.1 Overview: Global Predictive and Presymptomatic Testing Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Breast and Ovarian Cancer
1.4.3 Colorectal Cancer
1.4.4 Alzheimer's Disease
1.4.5 Multiple Endocrine Neoplasia Type 2
1.4.6 Haemochromatosis
1.5 Global Predictive and Presymptomatic Testing Market Size & Forecast
1.6 Global Predictive and Presymptomatic Testing Market Size and Forecast by Region
1.6.1 Global Predictive and Presymptomatic Testing Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Predictive and Presymptomatic Testing Market Size by Region, (2020-2031)
1.6.3 North America Predictive and Presymptomatic Testing Market Size and Prospect (2020-2031)
1.6.4 Europe Predictive and Presymptomatic Testing Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Predictive and Presymptomatic Testing Market Size and Prospect (2020-2031)
1.6.6 South America Predictive and Presymptomatic Testing Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Predictive and Presymptomatic Testing Market Size and Prospect (2020-2031)
2 Company Profiles
2.1 23andMe, Inc.
2.1.1 23andMe, Inc. Details
2.1.2 23andMe, Inc. Major Business
2.1.3 23andMe, Inc. Predictive and Presymptomatic Testing Product and Solutions
2.1.4 23andMe, Inc. Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 23andMe, Inc. Recent Developments and Future Plans
2.2 Abbott Molecular, Inc.
2.2.1 Abbott Molecular, Inc. Details
2.2.2 Abbott Molecular, Inc. Major Business
2.2.3 Abbott Molecular, Inc. Predictive and Presymptomatic Testing Product and Solutions
2.2.4 Abbott Molecular, Inc. Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Abbott Molecular, Inc. Recent Developments and Future Plans
2.3 BioAxis DNA Research Centre Private Limited
2.3.1 BioAxis DNA Research Centre Private Limited Details
2.3.2 BioAxis DNA Research Centre Private Limited Major Business
2.3.3 BioAxis DNA Research Centre Private Limited Predictive and Presymptomatic Testing Product and Solutions
2.3.4 BioAxis DNA Research Centre Private Limited Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 BioAxis DNA Research Centre Private Limited Recent Developments and Future Plans
2.4 Color Genomics, Inc.
2.4.1 Color Genomics, Inc. Details
2.4.2 Color Genomics, Inc. Major Business
2.4.3 Color Genomics, Inc. Predictive and Presymptomatic Testing Product and Solutions
2.4.4 Color Genomics, Inc. Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Color Genomics, Inc. Recent Developments and Future Plans
2.5 Direct Laboratory Services LLC (DirectLabs)
2.5.1 Direct Laboratory Services LLC (DirectLabs) Details
2.5.2 Direct Laboratory Services LLC (DirectLabs) Major Business
2.5.3 Direct Laboratory Services LLC (DirectLabs) Predictive and Presymptomatic Testing Product and Solutions
2.5.4 Direct Laboratory Services LLC (DirectLabs) Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Direct Laboratory Services LLC (DirectLabs) Recent Developments and Future Plans
2.6 Gene by Gene Ltd.
2.6.1 Gene by Gene Ltd. Details
2.6.2 Gene by Gene Ltd. Major Business
2.6.3 Gene by Gene Ltd. Predictive and Presymptomatic Testing Product and Solutions
2.6.4 Gene by Gene Ltd. Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Gene by Gene Ltd. Recent Developments and Future Plans
2.7 Genomic Diagnostics
2.7.1 Genomic Diagnostics Details
2.7.2 Genomic Diagnostics Major Business
2.7.3 Genomic Diagnostics Predictive and Presymptomatic Testing Product and Solutions
2.7.4 Genomic Diagnostics Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Genomic Diagnostics Recent Developments and Future Plans
2.8 Mapmygenome
2.8.1 Mapmygenome Details
2.8.2 Mapmygenome Major Business
2.8.3 Mapmygenome Predictive and Presymptomatic Testing Product and Solutions
2.8.4 Mapmygenome Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Mapmygenome Recent Developments and Future Plans
2.9 Myriad Genetics, Inc.
2.9.1 Myriad Genetics, Inc. Details
2.9.2 Myriad Genetics, Inc. Major Business
2.9.3 Myriad Genetics, Inc. Predictive and Presymptomatic Testing Product and Solutions
2.9.4 Myriad Genetics, Inc. Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Myriad Genetics, Inc. Recent Developments and Future Plans
2.10 Pathway Genomics Corporation
2.10.1 Pathway Genomics Corporation Details
2.10.2 Pathway Genomics Corporation Major Business
2.10.3 Pathway Genomics Corporation Predictive and Presymptomatic Testing Product and Solutions
2.10.4 Pathway Genomics Corporation Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Pathway Genomics Corporation Recent Developments and Future Plans
2.11 Positive Bioscience, Inc.
2.11.1 Positive Bioscience, Inc. Details
2.11.2 Positive Bioscience, Inc. Major Business
2.11.3 Positive Bioscience, Inc. Predictive and Presymptomatic Testing Product and Solutions
2.11.4 Positive Bioscience, Inc. Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Positive Bioscience, Inc. Recent Developments and Future Plans
2.12 Quest Diagnostics, Inc.
2.12.1 Quest Diagnostics, Inc. Details
2.12.2 Quest Diagnostics, Inc. Major Business
2.12.3 Quest Diagnostics, Inc. Predictive and Presymptomatic Testing Product and Solutions
2.12.4 Quest Diagnostics, Inc. Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Quest Diagnostics, Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Predictive and Presymptomatic Testing Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Predictive and Presymptomatic Testing by Company Revenue
3.2.2 Top 3 Predictive and Presymptomatic Testing Players Market Share in 2024
3.2.3 Top 6 Predictive and Presymptomatic Testing Players Market Share in 2024
3.3 Predictive and Presymptomatic Testing Market: Overall Company Footprint Analysis
3.3.1 Predictive and Presymptomatic Testing Market: Region Footprint
3.3.2 Predictive and Presymptomatic Testing Market: Company Product Type Footprint
3.3.3 Predictive and Presymptomatic Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Predictive and Presymptomatic Testing Consumption Value and Market Share by Type (2020-2025)
4.2 Global Predictive and Presymptomatic Testing Market Forecast by Type (2026-2031)
5 Market Size Segment by Application
5.1 Global Predictive and Presymptomatic Testing Consumption Value Market Share by Application (2020-2025)
5.2 Global Predictive and Presymptomatic Testing Market Forecast by Application (2026-2031)
6 North America
6.1 North America Predictive and Presymptomatic Testing Consumption Value by Type (2020-2031)
6.2 North America Predictive and Presymptomatic Testing Market Size by Application (2020-2031)
6.3 North America Predictive and Presymptomatic Testing Market Size by Country
6.3.1 North America Predictive and Presymptomatic Testing Consumption Value by Country (2020-2031)
6.3.2 United States Predictive and Presymptomatic Testing Market Size and Forecast (2020-2031)
6.3.3 Canada Predictive and Presymptomatic Testing Market Size and Forecast (2020-2031)
6.3.4 Mexico Predictive and Presymptomatic Testing Market Size and Forecast (2020-2031)
7 Europe
7.1 Europe Predictive and Presymptomatic Testing Consumption Value by Type (2020-2031)
7.2 Europe Predictive and Presymptomatic Testing Consumption Value by Application (2020-2031)
7.3 Europe Predictive and Presymptomatic Testing Market Size by Country
7.3.1 Europe Predictive and Presymptomatic Testing Consumption Value by Country (2020-2031)
7.3.2 Germany Predictive and Presymptomatic Testing Market Size and Forecast (2020-2031)
7.3.3 France Predictive and Presymptomatic Testing Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Predictive and Presymptomatic Testing Market Size and Forecast (2020-2031)
7.3.5 Russia Predictive and Presymptomatic Testing Market Size and Forecast (2020-2031)
7.3.6 Italy Predictive and Presymptomatic Testing Market Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Predictive and Presymptomatic Testing Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Predictive and Presymptomatic Testing Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Predictive and Presymptomatic Testing Market Size by Region
8.3.1 Asia-Pacific Predictive and Presymptomatic Testing Consumption Value by Region (2020-2031)
8.3.2 China Predictive and Presymptomatic Testing Market Size and Forecast (2020-2031)
8.3.3 Japan Predictive and Presymptomatic Testing Market Size and Forecast (2020-2031)
8.3.4 South Korea Predictive and Presymptomatic Testing Market Size and Forecast (2020-2031)
8.3.5 India Predictive and Presymptomatic Testing Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Predictive and Presymptomatic Testing Market Size and Forecast (2020-2031)
8.3.7 Australia Predictive and Presymptomatic Testing Market Size and Forecast (2020-2031)
9 South America
9.1 South America Predictive and Presymptomatic Testing Consumption Value by Type (2020-2031)
9.2 South America Predictive and Presymptomatic Testing Consumption Value by Application (2020-2031)
9.3 South America Predictive and Presymptomatic Testing Market Size by Country
9.3.1 South America Predictive and Presymptomatic Testing Consumption Value by Country (2020-2031)
9.3.2 Brazil Predictive and Presymptomatic Testing Market Size and Forecast (2020-2031)
9.3.3 Argentina Predictive and Presymptomatic Testing Market Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Predictive and Presymptomatic Testing Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Predictive and Presymptomatic Testing Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Predictive and Presymptomatic Testing Market Size by Country
10.3.1 Middle East & Africa Predictive and Presymptomatic Testing Consumption Value by Country (2020-2031)
10.3.2 Turkey Predictive and Presymptomatic Testing Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Predictive and Presymptomatic Testing Market Size and Forecast (2020-2031)
10.3.4 UAE Predictive and Presymptomatic Testing Market Size and Forecast (2020-2031)
11 Market Dynamics
11.1 Predictive and Presymptomatic Testing Market Drivers
11.2 Predictive and Presymptomatic Testing Market Restraints
11.3 Predictive and Presymptomatic Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Predictive and Presymptomatic Testing Industry Chain
12.2 Predictive and Presymptomatic Testing Upstream Analysis
12.3 Predictive and Presymptomatic Testing Midstream Analysis
12.4 Predictive and Presymptomatic Testing Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
23andMe, Inc.
Abbott Molecular, Inc.
BioAxis DNA Research Centre Private Limited
Color Genomics, Inc.
Direct Laboratory Services LLC (DirectLabs)
Gene by Gene Ltd.
Genomic Diagnostics
Mapmygenome
Myriad Genetics, Inc.
Pathway Genomics Corporation
Positive Bioscience, Inc.
Quest Diagnostics, Inc.
听
听
*If Applicable.
